$107.97
+27.20 (+33.68%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+142.74%
YTD
+21.49%
Open$93.74
Previous Close$80.77
Day High$111.50
Day Low$92.00
52W High$118.84
52W Low$36.98
Volume—
Avg Volume910.3K
Market Cap3.61B
P/E Ratio—
EPS$-9.75
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$97.75
Above
SMA 200
$64.49
Above
RSI (14)
50.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
15 analysts
Price Target
-68.9% upside
Current
$107.97
$107.97
Target
$33.59
$33.59
$28.45
$33.59 avg
$56.21
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 178.86M | 129.26M | 2.02B |
| Net Income | -496,264,148 | -322,785,093 | 154.03M |
| Profit Margin | -277.5% | -263.6% | 7.6% |
| EBITDA | -507,899,701 | -348,706,161 | 214.07M |
| Free Cash Flow | — | — | 137.52M |
| Rev Growth | +38.4% | +38.4% | +15.5% |
| Debt/Equity | — | — | 0.96 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |